Related Experiment Videos
Summary
Cisapride, a prokinetic agent, effectively improves upper gastrointestinal motility and emptying in renal patients undergoing long-term dialysis. While generally well-tolerated, common adverse effects include gastrointestinal issues like cramps and diarrhea.
Area of Science:
- Nephrology
- Gastroenterology
- Pharmacology
Background:
- Renal patients frequently experience vague abdominal symptoms suggestive of gastric motility disorders.
- Gastric stasis is a common complication in patients with chronic kidney disease and those on long-term dialysis.
Purpose of the Study:
- To evaluate the efficacy of cisapride in improving upper gastrointestinal motility and emptying in patients on long-term dialysis.
- To assess the safety and tolerability profile of cisapride in this patient population.
Main Methods:
- Administration of cisapride to patients on long-term dialysis experiencing upper gastrointestinal symptoms.
- Assessment of gastric motility and emptying parameters before and after cisapride treatment.
- Monitoring for adverse reactions and side effects.
Main Results:
- Cisapride significantly improved motility and emptying of the upper gastrointestinal tract.
- The drug is extensively metabolized in the liver, yielding metabolites with minimal pharmacologic activity.
- The primary adverse reactions observed were gastrointestinal, including abdominal cramps, flatulence, and diarrhea.
Conclusions:
- Cisapride is an effective prokinetic agent for managing upper gastrointestinal motility disorders in patients on long-term dialysis.
- The observed adverse effects are predominantly gastrointestinal and generally manageable.
- Further research may explore optimal dosing and long-term safety in this specific cohort.